News

Drug companies' lobbying of ministers has little effect on NICE

BMJ 2006; 333 doi: 10.1136/bmj.333.7571.719 (Published 5 October 2006)
Cite this as: BMJ 2006;333:719.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Andrew Jack, pharmaceutical correspondent
  1. Financial Times

    Aggressive lobbying of government ministers by drug companies seeking to overturn the judgments of the body that advises on the use of treatments by the NHS in England and Wales has had little effect on its decisions.

    Minutes of civil service meetings obtained by the Guardian (Sep 28, p 1) under freedom of information laws show that during the eight months to May this year senior executives from …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular